Osteoprotegerin mediates tumor-promoting effects of Interleukin-1beta in breast cancer cells
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Osteoprotegerin mediates tumor-promoting effects of Interleukin-1beta in breast cancer cells
Authors
Keywords
Breast cancer, Inflammation, Interleukin-1beta, Metastasis, Osteoprotegerin, p38 MAPK, p42/44 MAPK
Journal
Molecular Cancer
Volume 16, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-02-01
DOI
10.1186/s12943-017-0606-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages
- (2015) Takanori Kitamura et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The Role of Cytokines in Breast Cancer Development and Progression
- (2015) Marcela Esquivel-Velázquez et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Osteoprotegerin in breast cancer: beyond bone remodeling
- (2015) Michael Weichhaus et al. Molecular Cancer
- Upregulation of osteoprotegerin expression correlates with bone invasion and predicts poor clinical outcome in oral cancer
- (2015) G. Russmueller et al. ORAL ONCOLOGY
- The effects of lung and prostate cancer bone metastasis on serum osteoprotegerin levels: a meta-analysis
- (2015) Leyuan Zang et al. Scientific Reports
- Role of Inflammation-Associated Microenvironment in Tumorigenesis and Metastasis
- (2014) Feng Gao et al. CURRENT CANCER DRUG TARGETS
- IL-1β-induced activation of p38 promotes metastasis in gastric adenocarcinoma via upregulation of AP-1/c-fos, MMP2 and MMP9
- (2014) Qiaojia Huang et al. Molecular Cancer
- Targeting RAS–ERK signalling in cancer: promises and challenges
- (2014) Ahmed A. Samatar et al. NATURE REVIEWS DRUG DISCOVERY
- Zerumbone Suppresses IL-1β-induced Cell Migration and Invasion by Inhibiting IL-8 and MMP-3 Expression in Human Triple-negative Breast Cancer Cells
- (2014) Jeonghun Han et al. PHYTOTHERAPY RESEARCH
- Osteoprotegerin expression in triple-negative breast cancer cells promotes metastasis
- (2014) Michael Weichhaus et al. Cancer Medicine
- EZH2 inhibition decreases p38 signaling and suppresses breast cancer motility and metastasis
- (2013) Heather M. Moore et al. BREAST CANCER RESEARCH AND TREATMENT
- Serum levels of IL-6 and IL-1β can predict the efficacy of gemcitabine in patients with advanced pancreatic cancer
- (2013) S Mitsunaga et al. BRITISH JOURNAL OF CANCER
- Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer
- (2013) Kamal S. Saini et al. CANCER TREATMENT REVIEWS
- P38 MAPK Contributes to Resistance and Invasiveness of HER2- Overexpressing Breast Cancer
- (2013) S.M. Donnelly et al. CURRENT MEDICINAL CHEMISTRY
- Osteoprotegerin: Multiple partners for multiple functions
- (2013) Marc Baud’huin et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Role of Interleukin-1β in Radiation-Enhancement of MDA-MB-231 Breast Cancer Cell Invasion
- (2013) Benoit Paquette et al. RADIATION RESEARCH
- Interleukin-1 beta and transforming growth factor-beta 3 cooperate to activate matrix metalloproteinase expression and invasiveness in A549 lung adenocarcinoma cells
- (2012) Brenda L. Petrella et al. CANCER LETTERS
- Prognostic Significance of Tumor-Associated Macrophages in Solid Tumor: A Meta-Analysis of the Literature
- (2012) Qiong-wen Zhang et al. PLoS One
- Macrophages induce COX-2 expression in breast cancer cells: role of IL-1β autoamplification
- (2011) Zhe Hou et al. CARCINOGENESIS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Clinical Significance of Osteoprotegerin Expression in Human Colorectal Cancer
- (2011) S. Tsukamoto et al. CLINICAL CANCER RESEARCH
- p38 Mitogen-Activated Protein Kinase-Driven MAPKAPK2 Regulates Invasion of Bladder Cancer by Modulation of MMP-2 and MMP-9 Activity
- (2010) B. Kumar et al. CANCER RESEARCH
- Inflammation: A driving force speeds cancer metastasis
- (2010) Yadi Wu et al. CELL CYCLE
- Basal Subtype and MAPK/ERK Kinase (MEK)-Phosphoinositide 3-Kinase Feedback Signaling Determine Susceptibility of Breast Cancer Cells to MEK Inhibition
- (2009) O. K. Mirzoeva et al. CANCER RESEARCH
- In vivo Antitumor Activity of MEK and Phosphatidylinositol 3-Kinase Inhibitors in Basal-Like Breast Cancer Models
- (2009) K. P. Hoeflich et al. CLINICAL CANCER RESEARCH
- Stromal MCP-1 in mammary tumors induces tumor-associated macrophage infiltration and contributes to tumor progression
- (2009) Hiroshi Fujimoto et al. INTERNATIONAL JOURNAL OF CANCER
- Osteoprotegerin production by breast cancer cells is suppressed by dexamethasone and confers resistance against TRAIL-induced apoptosis
- (2009) Tilman D. Rachner et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- The MSX1 homeobox transcription factor is a downstream target of PHOX2B and activates the Delta–Notch pathway in neuroblastoma
- (2007) Ingrid Revet et al. EXPERIMENTAL CELL RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started